News for Industry
UCLA Researchers Identify Unique Protein Key to the Development of Blood Stem Cells (News Wise)
(Los Angeles, CA) UCLA scientists discover a new unique protein which is essential for the self-renewal of hematopoietic stem cells during human development.
Magnetic Nanoparticles Stimulate Stem Cells To Regenerate Better, Denser Bone (Street Insider)
(Stoke-On-Trent, UK) The possibility of a superior way to regrow bone tissue using magnetic nanoparticles coated with targeting proteins.
FDA Fast Tracks ALS Stem Cell Therapy (BioNews)
(Washington, DC) The United States food and drug administration FDA has granted fast-track status for a potential stem cell treatment of amyotrophic lateral sclerosis ALS.
Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank (CNN)
(Rancho Cordova, CA) Cesca Inc. successfully secured a contract to provide cell storage, processing and consumables platform to upstate medical University’s public cord blood bank.
MiMedx Third Quarter Revenue Of $33.5 Million Exceeds Upper End Of Guidance (CNN)
(Marietta, GA) MiMedx group Inc. is a leading regenerative medicine company utilizing human amniotic tissue reported record revenue for the 3rd quarter of 2014.
Bioheart Announces Positive 12 Month Preliminary Data From Phase I Angel Trial (Market Wired)
(Sunrise, FL) Bioheart, Inc released twelve-month data from its phase 1 ANGEL trial which is being conducted in Mexico.
Researchers Replicate Alzheimer’s Brain Cells In a Petri Dish (Boston Globe)
(Boston, MA) A petri dish with human brain cells that develop structures specific for Alzheimer’s disease, opening the door for potential drug therapy.
New Physical Makers for MSCs in Bone Marrow Identified (Imperial Valley News)
(Cambridge, MA) Researchers identify 3 physical characteristics of mesenchymal stem cells that can distinguish them from other immature cells found in bone marrow.
Stem Cell Agency Invests $16 million To Fight Diabetes (Imperial Valley News)
(San Francisco, CA) The California Institute for Regenerative Medicine (CIRM) awarded $60 million to researchers hoping to accelerate the development of a treatment for type I diabetes.